Audioboom Group – 1650p
24th May 2022
When we last commented on shares in Audioboom at the end of last month, we reduced our recommendation to hold following the strong run in the share price. ...
Read More
Share Watch
Hargreaves Services (HSP) – 410p
6th October 2021
Following a strong run since late 2020, shares in Hargreaves Services have slipped back to a level where they look very appealing once again...
Read More
Alumasc (ALU) – 210p
4th October 2021
Shares in Alumasc have taken a breather in recent weeks, having risen strongly over the last 18 months or so. We watched the company closely as it navigated the challenges associated with...
Read More
Surgical Innovations (SUN) – 2.7p
8th September 2021
Doncaster-based MS International has released final results for the year ended 30 April 2021 and although the shares have moved higher on the news, which was undoubtedly positive, they remain...
Read More
MS International (MSI) – 196.5p
23rd June 2021
Doncaster-based MS International has released final results for the year ended 30 April 2021 and although the shares have moved higher on the news, which was undoubtedly positive, they remain...
Read More
Appreciate Group (APP) – 38.4p
2nd June 2021
Last week AIM-listed Appreciate Group announced a new partnership with PayPoint and this will mean that its gifting products are offered to consumers via PayPoint's network of 28,000 retailer partner...
Read More
Titon Holdings (TON) – 130p
26th May 2021
AIM-listed Titon Holdings, a manufacturer and supplier of ventilation systems and window and door hardware, reported solid interim results on 13 May...
Read More
Symphony Environmental Technologies (SYM) – 18.75p
12th May 2021
Symphony Environmental Technologies describes itself as a global specialist in technologies that make plastic smarter. ...
Read More
CIP Merchant Capital (CIP) – 55p
5th May 2021
The closed-ended investment company, which is listed on AIM, was incorporated in Guernsey in 2017. ...
Read More
IMMUPHARMA (IMM) – 9.7p
28th April 2021
AIM-listed specialist drug discovery and development company ImmuPharma has been out of favour with investors recently and the shares are languishing at close to all-time lows....
Read More